Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer

被引：0
|
作者：
TJ Polascik
JD Pearson
AW Partin
Dr TJ Polascik
机构：
[1] James Buchanan Brady Urological Institute,
[2] The Johns Hopkins Medical Institutions,undefined
[3] Merck Research Laboratories,undefined
来源：
Prostate Cancer and Prostatic Diseases | 1998年 / 1卷
关键词：
prostate cancer; PSA; multivariate analysis; nomogram; staging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To benefit from definitive local therapy, men with clinically localized prostate cancer should have organ-confined disease. We discuss the use of multivariate analysis using serum PSA, biopsy Gleason score and clinical stage to improve the prediction of pathologic stage.
引用
收藏
页码：301 / 306
页数：5
相关论文
共 50 条
  • [21] Roach's mathematical equations in predicting pathological stage in men with clinically localized prostate cancer
    Medica, M
    Giglio, M
    Germinale, F
    Timossi, L
    Romagnoli, A
    Bertolotto, F
    Carmignani, G
    TUMORI, 2001, 87 (03) : 130 - 133
  • [22] The use of percent free prostate specific antigen for staging of men with clinically localized prostate cancer.
    Subong, E
    Pannek, J
    Chan, DW
    Epstein, JI
    Walsh, PC
    Partin, AW
    JOURNAL OF UROLOGY, 1998, 159 (05): : 294 - 294
  • [23] Safety of purified isoflavones in men with clinically localized prostate cancer
    Kumar, Nagi B.
    Krischer, Jeffrey P.
    Allen, Kathy
    Riccardi, Diane
    Besterman-Dahan, Karen
    Salup, Raoul
    Kang, Lovellen
    Xu, Ping
    Pow-Sang, Julio
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2007, 59 (02): : 169 - 175
  • [24] Prostatectomy and survival among men with clinically localized prostate cancer
    Lawrence, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (21): : 1724 - 1724
  • [25] Predicting life expectancy in men with clinically localized prostate cancer
    Cowen, ME
    Halasyamani, LK
    Kattan, MW
    JOURNAL OF UROLOGY, 2006, 175 (01): : 99 - 103
  • [26] Racial differences in prostate androgen levels in men with clinically localized prostate cancer
    Mohler, JL
    Gaston, KE
    Moore, DT
    Schell, MJ
    Cohen, BR
    Petrusz, P
    JOURNAL OF UROLOGY, 2004, 171 (04): : 221 - 221
  • [27] Racial differences in prostate androgen levels in men with clinically localized prostate cancer
    Mohler, JL
    Gaston, KE
    Moore, DT
    Schell, MJ
    Cohen, BL
    Weaver, C
    Petrusz, P
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2277 - 2280
  • [28] Testosterone as a predictor of pathological stage in clinically localized prostate cancer
    Isom-Batz, G
    Bianco, FJ
    Kattan, MW
    Mulhall, JP
    Lilja, H
    Eastham, JA
    JOURNAL OF UROLOGY, 2005, 173 (06): : 1935 - 1937
  • [29] The use of body mass index to predict pathological stage in patients with clinically localized prostate cancer
    Pummer, Karl
    Stettner, Haro
    Augustin, Herbert
    Zigeuner, Richard
    Habermann, Helga
    Schips, Luigi
    Riedler, Ildiko
    Trummer, Harald
    Lipsky, Kathrin
    Williams, Stephen B.
    ONKOLOGIE, 2007, 30 (10): : 489 - 494
  • [30] Are predictive models for cancer volume clinically useful in localized prostate cancer?
    Ishida, Masaru
    Nakashima, Jun
    Hashiguchi, Akinori
    Mizuno, Ryuichi
    Shinoda, Kazunobu
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Mukai, Makio
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (12) : 936 - 940
12345